Drug thefts are a growing problem at private hospitals as well as the government-run VA as the illegal use of opioids has increased in the United States. But the rate of reported missing drugs at VA health facilities was more than double that of the private sector.
WASHINGTON — Federal authorities are investigating dozens of new cases of possible opioid and other drug theft by employees at Veterans Affairs hospitals, a sign the problem isn’t going away.
Data obtained by The Associated Press show 36 criminal investigations opened by the VA inspector general’s office from Oct. 1 through May 19. It brings the total number of open criminal cases to 108 involving theft or unauthorized drug use. Most of those probes typically lead to criminal charges.
The numbers are an increase from a similar period in the previous year. The VA has pledged “zero tolerance” in drug thefts following an AP story in February about a sharp rise in reported cases of stolen or missing drugs at the VA since 2009. Doctors, nurses or pharmacy staff in the VA’s network of more than 160 medical centers and 1,000 clinics are suspected of siphoning away controlled substances for their own use or street sale — sometimes to the harm of patients — or drugs simply vanished without explanation.
DEA investigators cited in part a larger quantity of drugs kept in stock at the bigger VA medical centers to treat a higher volume of patients, both outpatient and inpatient, and for distribution of prescriptions by mail.
Most Read Nation & World Stories
- Sports on TV & radio: Local listings for Seattle games and events
- What happened when a Brooklyn neighborhood policed itself for five days VIEW
- No survivors found after plane that flew over DC and led to fighter jet scramble crashes in Virginia
- The revolt of the Christian home-schoolers VIEW
- Rise in sightings of honeybee swarms has U.K. beekeepers scrambling
Sen. Marco Rubio, R-Fla., said AP’s findings were “troubling.” He urged Congress to pass bipartisan accountability legislation he was co-sponsoring that would give the agency “the tools needed to dismiss employees engaged in misconduct.” The Senate is set to vote on the bill June 6.
“The theft and misuse of prescription drugs, including opioids, by some VA employees is a good example of why we need greater accountability at the VA,” Rubio said.
In February, the VA announced efforts to combat drug thefts, including employee drug tests and added inspections. Top VA officials in Washington led by VA Secretary David Shulkin pledged to be more active, holding conference calls with health facilities to develop plans and reviewing data to flag problems. The department said it would consider more internal audits.
Criminal investigators said it was hard to say whether new safeguards are helping.
“Prescription drug diversion is a multifaceted, egregious health care issue,” said Jeffrey Hughes, the acting VA assistant inspector general for investigations. “Veterans may be denied necessary medications or their proper dosage and medical records may contain false information to hide the diversion, further putting veterans’ health at risk.”
Responding, the VA said it was working to develop additional policies “to improve drug safety and reduce drug theft and diversion across the entire health care system.”
“We have security protocols in place and will continue to work hard to improve it,” Poonam Alaigh, VA’s acting undersecretary for health, told the AP.
In one case, a registered nurse in the Spinal Cord Injury Ward at the VA medical center in Richmond, Virginia, was recently sentenced after admitting to stealing oxycodone tablets and fentanyl patches from VA medication dispensers. The nurse said she would sometimes shortchange the amount of pain medication prescribed to patients, taking the remainder to satisfy her addiction.
Hughes cited in particular the risk of patient harm. “Health care providers who divert for personal use may be providing care while under the influence of narcotics,” he said.
AP’s story in February had figures documenting the sharp rise in drug thefts at federal hospitals, most of them VA facilities. Subsequently released DEA data provide more specific details of the problem at the VA. Drug losses or theft increased from 237 in 2009 to 2,844 in 2015, before dipping to 2,397 last year. In only about 3 percent of those cases have doctors, nurses or pharmacy employees been disciplined, according to VA data.
At private hospitals, reported drug losses or theft also rose — from 2,023 in 2009 to 3,185 in 2015, before falling slightly to 3,154 last year. There is a bigger pool of private U.S. hospitals, at least 4,369, according to the American Hospital Association. That means the rate of drug loss or theft is lower than VA’s.
The VA inspector general’s office said it had opened 25 cases in the first half of the budget year that began Oct. 1. That is up from 21 in the same period in 2016.
The IG’s office said the number of newly opened criminal probes had previously been declining since 2014.
Michael Glavin, an IT specialist at the VA, says he’s heard numerous employee complaints of faulty VA technical systems that track drug inventories, leading to errors and months of delays in identifying when drugs go missing. Prescription drug shipments aren’t always fully inventoried when they arrive at a VA facility, he said, making it difficult to determine if a drug was missing upon arrival or stolen later.
“It’s still the same process,” said Glavin, who heads the local union at the VA medical center in Columbia, Missouri. The union’s attorney, Natalie Khawam, says whistleblowers at other VA hospitals have made similar complaints.
Criminal investigators stressed the need for a continuing drug prevention effort. The VA points to inventory checks every 72 hours and “double lock and key access” to drugs. It attributes many drug loss cases to reasons other than employee theft, such as drugs lost in transit. But the DEA says some of those cases may be wrongly classified.
“Inventories are always an issue as to who’s watching or checking it,” said Tom Prevoznik, a DEA deputy chief of pharmaceutical investigations. “What are the employees doing, and who’s watching them?”
Follow Hope Yen on Twitter at https://twitter.com/hopeyen1